Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy in Kala-azar

N K Singh1, T K Jha, I J Singh

  • 1Kala-azar Research Centre, Barhmpura, Muzaffarpur.

The Journal of the Association of Physicians of India
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biochemical and growth responses of mungbean to actinobacterial inoculation under water stress.

Scientific reports·2026
Same author

In Reply.

International journal of oral and maxillofacial surgery·2026
Same author

Cognitive Impairment in Autoimmune Encephalitis: Characterization and Predicting Long-term Outcomes.

Neurology India·2025
Same author

Effect of a Year-long Yoga-Based Lifestyle Intervention on Glycemic Control, Body Weight, Psychological Health, and Imaging Biomarkers in Adults with Type 2 Diabetes: A Randomized Controlled Trial.

Advances in mind-body medicine·2025
Same author

NEXTODERM: Consensus on Dermatophytosis Diagnosis and Management in Nepal.

Dermatology research and practice·2025
Same author

Papilliferous keratoameloblastoma: a case report with review of the literature.

International journal of oral and maxillofacial surgery·2025

This study found that combining Sodium Stibogluconate (SSG) with allopurinol did not improve Kala-azar treatment outcomes compared to SSG alone. Further research is needed to explore effective combination therapies for visceral leishmaniasis.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Pharmacology

Background:

  • Kala-azar, also known as visceral leishmaniasis, is a severe parasitic disease.
  • Sodium Stibogluconate (SSG) is a primary treatment, but resistance is a growing concern.
  • Investigating combination therapies aims to enhance efficacy and overcome resistance.

Purpose of the Study:

  • To evaluate the efficacy of combination therapies for Kala-azar.
  • To compare SSG monotherapy with SSG combined with allopurinol, ketoconazole, or levamisole.

Main Methods:

  • 128 untreated Kala-azar patients were divided into four groups.
  • Group A received SSG alone.
  • Groups B, C, and D received SSG combined with allopurinol, ketoconazole, or levamisole, respectively, for 30 days.

Related Experiment Videos

Main Results:

  • Combination therapy with allopurinol and SSG showed no statistically significant improvement over SSG monotherapy.
  • Efficacy data for ketoconazole and levamisole combinations were compared to the SSG-alone group.

Conclusions:

  • Allopurinol in combination with SSG does not offer a statistically significant advantage over SSG monotherapy for Kala-azar treatment.
  • Further studies are warranted to explore alternative or optimized combination strategies for visceral leishmaniasis.